Brief: Chemometec Adjusts Upwards Expectation For Revenue And EBITDA For 2018/19
25/04/2019 07:41
April 25 (Reuters) - Chemometec A/S CHEMM.CO :
* AS A RESULT OF BETTER THAN EXPECTED DEVELOPMENT, CO
ADJUSTS
UPWARDS EXPECTATION FOR REVENUE AND EBITDA FOR 2018/19
* 2018/19 EXPECTS A REVENUE AT DKK 162-170 MILLION, AGAINST
PREVIOUSLY DKK 150-157 MILLION, WITH EBITDA NOW EXPECTED AT THE
LEVEL OF DKK 56-61 MILLION AGAINST PREVIOUSLY DKK 50-55 MILLION
Source text for Eikon: ID:nGNE1Gtdm6
Further company coverage: CHEMM.CO
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 587720920;))
Recent news on ChemoMetec A/S
See all newsDenmark's Chemometec Q1 revenue rises 28% on instrument sales
Brief: Chemometec Q1 EBITDA DKK 100.3 Million
Denmark's ChemoMetec lifts FY outlook on strong instrument demand, lower costs
Brief: Chemometec Raises 2026/27 EBITDA Guidance To DKK 335-360 Million
Brief: Chemometec A/S Says Board Initiates Share Buy-Back Based On AGM Authorisation